Institutions will accumulate to 90% and technical need to catch up. Insiders own 10%.
Once the above are done, the switch will be flipped to over $25.
In the bigger picture, China dumped $120 billion into biotech R and D.
In order for U.S. to maintain our 25% of global GDP and not through leveraged debt, we need more leading edge companies like Tesla and Celldex. We need them for the economy, jobs, main street, wall street, and the Fed.
And most importantly, irrespective of everything else, the patients want and need this to succeed.
CLDX has been forming a classic bullish pennant/flag continuation pattern for the past seven trading days. There's no telling how much longer the pattern will persist, but when the price breaks out of the pattern to close above $22 the stock should resume its upward trend with resistance somewhere between $26 and $28 before consolidating some more.